ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

0.04 0.01 (33.33%)  02-20 11:15
Open: 0.04 Prev Close: 0.03
High: 0.04 Low: 0.04
Volume: 24,000 Market Cap: 0M
Year High: 0.79 Year Low: 0.02
Stock Technical Analysis
Targets Six months: 0.1172    One year: 0.1752
Supports Support1: 0.0200   Support2: 0.0166
Resistances Resistance1: 0.1003    Resistance2: 0.1500 
Pivot Point 0.0370 
Moving Averages MA(5): 0.0380      MA(20): 0.0388 

MA(100): 0.0590  -1     MA(250): 0.2821 
MACD MACD(12,26): -0.001      Signal(12,26,9): -0.001 
Stochastic Oscillator %K(14,3): 26.667      %D(3): 20.556 
RSI RSI(14): 50.991 
52-Week High: 0.7900  Low: 0.0200  Change(%): -94
Average Volume(K) 3-Month: 2487  10-Days: 243
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is above its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BULLISH in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed below upper band by 38.6%; above bottom band by 61.4%; Bollinger Bands are 60.9% narrower than normal.The narrow width of the bands suggests low volatility as compared to NSPX's normal range. The bands have been in this narrow range for 87 bars. This is often a sign that a market may be about to initiate a new trend.


Stock Chart

Top 100 stocks

Stock News
Inspyr Therapeutics Appoints NIH Veterans to Lead New Translational Medicine ...
Mon, 06 Mar 2017 13:52:30 GMT

Inspyr Therapeutics Secures a $100 Million Financing Agreement from Milost Global
Fri, 17 Mar 2017 12:56:15 GMT

Inspyr Therapeutics Signs Commitment Letter with Milost Global
Tue, 28 Mar 2017 12:56:15 GMT

Inspyr Therapeutics and Lewis and Clark Pharmaceuticals to Merge
Tue, 30 May 2017 20:26:15 GMT

Inspyr Therapeutics Appoints Christopher Lowe Chief Executive Officer and Director
Thu, 04 Aug 2016 10:52:30 GMT

Inspyr Therapeutics and Lewis and Clark Pharmaceuticals Complete Merger
Wed, 13 Sep 2017 12:56:15 GMT

Inspyr Therapeutics Announces Private Placement of Senior Convertible Debentures
Tue, 12 Sep 2017 13:41:15 GMT

Inspyr Therapeutics Initiates Mipsagargin Combination Therapy Program for ...
Wed, 22 Feb 2017 13:52:30 GMT

Inspyr Therapeutics Announces Research Collaboration with the National ...
Mon, 23 Oct 2017 12:56:15 GMT

Which Way Is Inspyr Therapeutics Inc (NSPX) Trending?
Tue, 20 Feb 2018 22:18:45 GMT